Recommendations for the treatment of Parkinson disease;Recommandations pour le traitement de la maladie de Parkinson

Schweizer Archiv fur Neurologie und Psychiatrie

Volumn 155, Issue 2, 2004, Pages 74-83

  Ludin, H P ^a,b   Baronti, F ^b   Burkhard, P ^b   Fuhr, P ^b   Ghika, J ^b   Staedler, C ^b   Sturzenegger, M ^b   Vingerhoets, F ^b   Waldvogel, D ^b  

^a Neurologie FMH   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMANTADINE SULFATE; ANTIDEPRESSANT AGENT; APOMORPHINE; ATYPICAL ANTIPSYCHOTIC AGENT; BENSERAZIDE PLUS LEVODOPA; BIPERIDEN; BROMOCRIPTINE MESILATE; CABERGOLINE; CARBIDOPA PLUS LEVODOPA; CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; CRIPAR; DECARBOXYLASE INHIBITOR; DIHYDROERGOCRYPTINE; DOMPERIDONE; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; HELVEPHARM; LEVODOPA; LISURIDE MALEATE; PERGOLIDE MESILATE; PRAMIPEXOLE; QUETIAPINE; REGEPAR; ROPINIROLE; SELECIM; SELEGILIN; SELEGILINE; SELEGILINMEPHA; TOLCAPONE;

DYSKINESIA; DYSTONIA; PARKINSON DISEASE; PRACTICE GUIDELINE; REVIEW; STEREOTAXIC SURGERY;

EID: 1842482272     PISSN: 02587661     EISSN: None     Source Type: Journal    
DOI: 10.4414/sanp.2004.01457     Document Type: Review

References (1)

1. Groupe de travail de la commission de thérapie de la Sociéité Suisse de Neurologie (SSN). Recommandations pour le traitement du syndrome de Parkinson idiopathique. Bull Mdd Suisses 1998;79:425-7.